🇫🇷
France · FR · FR:63112361
REVESTIVE 1,25 mg, poudre et solvant pour solution injectable
ReimbursedATC A16AX08
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
CountryFR (France)
ATC codeA16AX08
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340093011505328 flacon(s) en verre de 1,25 mg - 28 seringue(s) préremplie(s) en verre de 0,5 ml avec piston(s)EUR 6.44
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "63112361",
"date_amm": "2017-06-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/787",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}Related drugs
Other records sharing ATC code A16AX08.
- 🇺🇸GattexTakeda Pharmaceuticals America, Inc.
- DKNilletoAdAlvo Limited
- DKRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- PLRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- ISRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- DKRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- ISRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- FIRevestiveTakeda Pharmaceuticals International AG Ireland Branch
Access this data programmatically
Query REVESTIVE 1,25 mg, poudre et solvant pour solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.